© Copyright 2024 Fresh Aesthetics   /   Branding and Website by Creatif
TGA Cosmetic Injectables

Updates for 2024

The Therapeutic Goods Administration’s (TGA) recent announcement regarding stricter regulations on advertising cosmetic injectables has brought significant changes to the industry. Effective immediately, general terms such as ‘anti-wrinkle injections’ and ‘dermal fillers’ are banned in advertising because they refer to prescription-only products.

The TGA advises clinics to use alternatives to describe the indications we treat, what causes them and how patients can recognise them. This change ensures that decisions about treatments involving prescription medicines are made during a consultation with a healthcare professional, not influenced by advertising.

The TGA’s updated guidelines also prohibit the use of specific product names, acronyms, and abbreviations in advertising. The goal is to ensure advertising focuses on the service provided rather than the prescription medicines used. This includes not only names but also testimonials, before-and-after photos, and price lists. The TGA will monitor compliance and conduct industry information sessions to educate and guide clinics on these new regulations.


Understanding the Changes in Our Services

Due to these new regulations, we have updated the names of our offerings to comply with TGA guidelines.
While you won’t see us mention terms like ‘botox’  or ‘lip fillers’ in our marketing, the same level of high-quality services are still offered after a consultation with our skilled nurses to address your aesthetics needs.

These changes help us to better serve you by ensuring our practices are safe and compliant with regulations. If you have any questions about these updates or need further clarification, please don’t hesitate to contact us or schedule a consultation. We’re here to discuss your needs and how we can address them with the full range of treatments we provide.

Contact Us